Hepatitis B virus, the vaccine, and the control of primary cancer of the liver
Open Access
- 8 July 1997
- journal article
- review article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 94 (14) , 7121-7125
- https://doi.org/10.1073/pnas.94.14.7121
Abstract
Viral hepatitis is an inflammation of the liver caused by at least six different, mostly unrelated, viruses [hepatitis viruses A, B, C, D, E, and G (HAV, HBV, HCV, HDV, HEV, and HGV, respectively)]. It can occur in an acute form from which most patients experience a complete recovery. Acute viral hepatitis is characterized by an insidious onset, often with fever and severe malaise and loss of appetite for food, alcohol, and tobacco. Flu-like symptoms may occur early in the illness. The characteristic finding that occurs in many cases is the development of jaundice, a dramatic yellow discoloration of the skin and other surfaces. Symptoms may last for days or weeks. The acute disease usually results in complete recovery with lifelong immunity. Occasionally, acute hepatitis may advance to the fulminant phase; the patient does not recover, but develops liver failure and death may be rapid. Fortunately, this is rare. Hepatitis due to HAV and HEV is nearly always acute. Acute disease also may occur with HBV and probably HGV. HCV is usually chronic.Keywords
This publication has 4 references indexed in Scilit:
- Complex interactions of hepatitis B virus with its host and environment. The Croonian Lecture 1994.1995
- Viral hepatitis and hepatocellular carcinoma.1994
- VIRAL HEPATITIS AND HEPATOCELLULAR CARCINOMAGastroenterology Clinics of North America, 1994
- Australia Antigen and the Biology of Hepatitis BScience, 1977